Trinseo (TSE) Projected to Post Quarterly Earnings on Thursday

Trinseo (NYSE:TSE) is expected to be releasing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Trinseo to post earnings of ($1.96) per share and revenue of $792.00 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Friday, November 7, 2025 at 10:30 AM ET.

Trinseo (NYSE:TSE) last posted its earnings results on Wednesday, August 6th. The basic materials company reported ($2.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.49) by ($0.63). The company had revenue of $784.30 million for the quarter, compared to analysts’ expectations of $966.82 million. On average, analysts expect Trinseo to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Trinseo Stock Down 7.8%

TSE stock opened at $1.37 on Wednesday. Trinseo has a 52 week low of $1.32 and a 52 week high of $6.85. The company has a fifty day simple moving average of $2.13 and a two-hundred day simple moving average of $2.71. The firm has a market capitalization of $49.07 million, a P/E ratio of -0.12 and a beta of 1.52.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on TSE shares. Zacks Research cut shares of Trinseo from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 21st. Weiss Ratings restated a “sell (d-)” rating on shares of Trinseo in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Insider Transactions at Trinseo

In related news, Director Matthew Farrell bought 48,609 shares of the stock in a transaction that occurred on Thursday, August 14th. The stock was bought at an average cost of $2.43 per share, for a total transaction of $118,119.87. Following the purchase, the director directly owned 250,225 shares of the company’s stock, valued at approximately $608,046.75. This trade represents a 24.11% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last quarter, insiders bought 100,000 shares of company stock worth $240,028. Corporate insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Trinseo

Large investors have recently modified their holdings of the business. Sugar Maple Asset Management LLC acquired a new stake in shares of Trinseo during the 2nd quarter worth approximately $41,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Trinseo in the 2nd quarter valued at $58,000. New York State Common Retirement Fund acquired a new position in Trinseo in the 2nd quarter valued at about $92,000. Dynamic Technology Lab Private Ltd acquired a new position in Trinseo in the 1st quarter valued at about $118,000. Finally, BNP Paribas Financial Markets grew its position in Trinseo by 80.2% in the 2nd quarter. BNP Paribas Financial Markets now owns 41,586 shares of the basic materials company’s stock valued at $130,000 after acquiring an additional 18,508 shares in the last quarter. Hedge funds and other institutional investors own 82.69% of the company’s stock.

About Trinseo

Trinseo PLC operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally. It operates through five segments: Engineered Materials, Latex Binders, Plastics Solutions, Polystyrene, and Americas Styrenics. The Engineered Materials segment offers rigid thermoplastic compounds and blends, soft thermoplastic, continuous cast, cell cast, activated methyl methacrylates (MMA), PMMA resins, and extruded PMMA sheets and resins for consumer electronics, medical, footwear, automotive, and building and construction applications under the EMERGE, CALIBRE, PLEXIGLAS, ALTUGLAS, ACRYSPA, AVONITE, STUDIO, MEGOL, APILON, APIGO, and APINAT brands.